Stay updated with breaking news from Nasdaq Codx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Co-Diagnostics Inc. (NASDAQ:CODX) went up by 12.50% from its latest closing price compared to the recent 1-year high of $20.69. The company’s stock price has collected -11.57% of loss in the last five trading sessions. Press Release reported on 11/15/21 that Co-Diagnostics, Inc. to Host Booth at M
Co-Diagnostics turns 1Q net profit of nearly $8M on strong sales of its Logix Smart COVID-19 Test Fueled by $20 million in revenue, net income was $7.9 million as compared to a net loss of $1.1 million in the prior-year quarter Looking to the second quarter, Co-Diagnostics gave revenue guidance in the range of $20 million to $22 million Co-Diagnostics Inc (NASDAQ:CODX) reported that it earned a first-quarter net profit -- versus a loss last year -- on strong sales of its Logix Smart COVID-19 Test. For the quarter ended March 31, the company said income before taxes was $9.9 mill...
Co-Diagnostics says its CoSara joint venture in India garnering media attention as it combats coronavirus surge In particular, the Indian media have noted the extraordinary efforts of a CoSara team of six women who have increased capacity from roughly 8,000 coronavirus PCR tests per day a year ago to around 40,000 per day now In April 2020, CoSara, a joint venture with Synbiotics, became the first company headquartered in India to get a license to manufacture coronavirus test kits Co-Diagnostics Inc (NASDAQ:CODX) has noted that its Indian manufacturing facility, CoSara Diagnost...